Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging

Title
Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 16, Issue 5, Pages e226-e233
Publisher
Elsevier BV
Online
2015-04-30
DOI
10.1016/s1470-2045(15)70075-6

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More